Skip to content
value.today

Tula Health, Inc.

🇺🇸 Kaysville, Utah, USAHealth CareFounded 2019
Total raised
$38 M
6 rounds on record
Latest round
$3 M
Jan 2022
First round on record
May 2019
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Tula Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2022$3 MNo. 6$2 to $10 million

Tula Health, Inc.: Raise no. 6, Jan 2022

Investors in this round

1 investor had bought by the notice of Feb 14, 2022: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$2,500,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Derrick · Executive Officer
  • David Miller · Executive Officer, Director
  • Doug Haymore · Executive Officer, Director
  • Jeffrey Peterson · Executive Officer
  • Jerry Henley · Executive Officer
  • Mitchell Weaver · Executive Officer
  • Marc Probst · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey Peterson, Cfo. Newest notice filed Feb 14, 2022. Read the notice at the SEC.

equitySEC
Dec 2021$1 MNo. 5Under $2 million

Tula Health, Inc.: Raise no. 5, Dec 2021

Investors in this round

8 investors had bought by the notice of Feb 11, 2022: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$99,000
What was sold
equity, other: Redemption offer
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Derrick · Executive Officer
  • David Miller · Executive Officer, Director
  • Doug Haymore · Executive Officer, Director
  • Jeffrey Peterson · Executive Officer
  • Jerry Henley · Executive Officer
  • Mitchell Weaver · Executive Officer
  • Marc Probst · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey Peterson, Cfo. Newest notice filed Feb 11, 2022. Read the notice at the SEC.

equitySEC
Aug 2021$8 MNo. 4$2 to $10 million

Tula Health, Inc.: Raise no. 4, Aug 2021

Investors in this round

7 investors had bought by the notice of Nov 12, 2021: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
$2,940
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Derrick · Executive Officer
  • David Miller · Executive Officer, Director
  • Doug Haymore · Executive Officer, Director
  • Jeffrey Peterson · Executive Officer
  • Jerry Henley · Executive Officer
  • Mitchell Weaver · Executive Officer
  • Marc Probst · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Derrick, Ceo. Newest notice filed Nov 12, 2021. Read the notice at the SEC.

equitySEC
Nov 2020$17 MNo. 3$10 to $50 million

Tula Health, Inc.: Raise no. 3, Nov 2020

Investors in this round

1 investor had bought by the notice of Aug 13, 2021: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
$17,000,000
What was sold
equity, debt, securities to be acquired by exercising them, other: Promissory Note; Equity Securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Jones · Executive Officer
  • David Derrick · Executive Officer
  • David Miller · Executive Officer, Director
  • Doug Haymore · Executive Officer
  • Jeffrey Peterson · Executive Officer
  • Alan Hall · Director
  • Austin Walters · Director
  • Marc Probst · Director
  • Ryan Brooks · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Doug Haymore, Ceo. Newest notice filed Aug 13, 2021. Read the notice at the SEC.

equity, debtSEC
Sep 2020$6 MNo. 2$2 to $10 million

Tula Health, Inc.: Raise no. 2, Sep 2020

Investors in this round

7 investors had bought by the notice of Aug 13, 2021: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$50,000
What was sold
equity, securities to be acquired by exercising them, other: Convertible Promissory Note
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Jones · Executive Officer
  • David Derrick · Executive Officer
  • David Miller · Executive Officer, Director
  • Doug Haymore · Executive Officer
  • Doug Haymore · Executive Officer
  • Jeffrey Peterson · Executive Officer
  • Alan Hall · Director
  • Austin Walters · Director
  • Marc Probst · Director
  • Ryan Brooks · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Doug Haymore, Ceo. Newest notice filed Aug 13, 2021. Read the notice at the SEC.

equitySEC
May 2019$3 MNo. 1$2 to $10 million

Tula Health, Inc.: Raise no. 1, May 2019

Investors in this round

26 investors had bought by the notice of Oct 23, 2019: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$100,002
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$532,944
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Doug Haymore · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Crewe Capital, LLC (CRD 152527) · Salt Lake City, UtahSold in AZ, CA, CO, FL, ID, ME, MT, NJ, NM, NV, NY, UT, WA

Remarks in the notice

  • On fees: “The placement agent will receive warrants or similar instruments of three percent (3.0%) of the fully-diluted shares outstanding of the Filer post-closing with an exercise price equal to $6.00 per share.”

Signed by Doug Haymore, Ceo. Newest notice filed Oct 23, 2019. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Tula Health, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2022).

    SEC Form D · Feb 2022

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2022

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Tula Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Tula Health, Inc.
NameRoleNamed in
David DerrickExecutive officerFeb 2022
David MillerExecutive officerFeb 2022
Doug HaymoreExecutive officerFeb 2022
Jeffrey PetersonExecutive officerFeb 2022
Jerry HenleyExecutive officerFeb 2022
Mitchell WeaverExecutive officerFeb 2022
Christopher JonesExecutive officerAug 2021
David MillerDirectorFeb 2022
Doug HaymoreDirectorFeb 2022
Marc ProbstDirectorFeb 2022
Alan HallDirectorAug 2021
Austin WaltersDirectorAug 2021
Ryan BrooksDirectorAug 2021